Glaxo Trizivir And Agenerase EU Labeling Will Allow Reduced Pill Burden
Executive Summary
Glaxo Wellcome's Trizivir will allow a reduced pill burden for treatment-naive HIV patients in the EU, following recommendation by EMEA's Committee for Proprietary Medicinal Products June 29.